SPIA
BCYC

Steward Partners Investment Advisory’s Bicycle Therapeutics BCYC Stock Holding History

Steward Partners Investment Advisory’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10
Closed -$85 – 4130
2025
Q1 		$85 Hold
10
– – ﹤0.01% 3948
2024
Q4 		$140 Buy
+10
New +$214 ﹤0.01% 3914

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Steward Partners Investment Advisory's BCYC Position: Q2 2025 in Review

Steward Partners Investment Advisory sold out of Bicycle Therapeutics (BCYC) in Q2 2025, closing a stake of 10 shares — an estimated $85 sold.

Steward Partners Investment Advisory first reported a position in BCYC in Q4 2024 and held it in 2 quarters. The position peaked at $140 in Q4 2024. 110 funds tracked by Wall St. Rank hold BCYC as of Q2 2025.

  • Steward Partners Investment Advisory reported no remaining Bicycle Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 10 Bicycle Therapeutics shares in Q2 2025, an estimated $85.
  • Steward Partners Investment Advisory first reported a position in Bicycle Therapeutics in Q4 2024 and held it in 2 quarters.
  • Steward Partners Investment Advisory's Bicycle Therapeutics position peaked at $140 in Q4 2024.
  • 110 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2025.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2025, filed 12 Aug 2025.